TPST · Tempest Therapeutics, Inc.
AI read · Bad for TPST
The AI's read
The missed deadline puts Tempest's Nasdaq listing at risk and points to a need for more cash. The hearing request pauses suspension or delisting, and its stock can keep trading before the hearing. Tempest cannot promise it will win the appeal or remain listed afterward.